Keen Eye Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 45

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.33M

  • Investors
  • 3

Keen Eye General Information

Description

Developer of a healthcare technology platform designed to build machine learning tools for translational and clinical research. The company's technology permits doctors and biologists to reproduce and extend their visual expertise, notably by identifying signals with a high predictive value that are yet difficult to detect, enabling medical practitioners to save valuable time in day-to-day decision-making, whether it is to diagnose, screen disease or evaluate the effectiveness of a drug in a more precise and standardized way

Contact Information

Website
www.keeneye.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Discovery Tools (Healthcare)
Primary Office
  • 74 rue du Faubourg Saint-Antoine
  • 75012 Paris
  • France
+33 01 00 00 00 00

Keen Eye Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Keen Eye Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 31-Dec-2019 $3.33M 0000 00.00 Completed Generating Revenue
7. Later Stage VC (Series A) 29-Apr-2019 00.000 00.000 000.00 Completed Generating Revenue
6. Seed Round 12-Dec-2016 00.00 00.000 00.000 Completed Generating Revenue
5. Angel (individual) 15-Jun-2016 000.00 00000 00.000 Completed Startup
4. Angel (individual) 01-Dec-2015 000.00 00000 00.000 Completed Startup
3. Angel (individual) 23-May-2015 000.00 00000 00.000 Completed Startup
2. Angel (individual) 26-Dec-2014 $142K $142K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Keen Eye’s complete valuation and funding history, request access »

Keen Eye Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P-2020 Shares 000,000 00.000000 000.00 000.00 00 000.00 00.000
P-2019 Shares 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
P-2016 Shares 00,000 00.000000 000.00 000.00 00 000.00 00.000
O Shares 0,000 00.000000 000.00 000.00 00 000.00 0.000
O Shares 0,000 00.000000 000.0 000.0 00 000.0 0.000
O Shares 900 $0.011107 $34.12 $34.12 1x $34.12 0.26%
O Shares 3,800 $0.011107 $33.6 $33.6 1x $33.6 1.11%
To view Keen Eye’s complete cap table history, request access »

Keen Eye Patents

Keen Eye Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3593320-A1 Automated reconstruction method of filament network Pending 07-Mar-2017 00000000
EP-3479339-A1 Multimodal viewer Granted 30-Jun-2016 00000000
JP-6908232-B2 Multimodal viewer Active 30-Jun-2016 00000000
US-11004171-B2 Multimodal viewer Active 30-Jun-2016 00000000 0
ES-2805804-T3 Multimodal viewer Active 30-Jun-2016 G06T1/60
To view Keen Eye’s complete patent history, request access »

Keen Eye Executive Team (10)

Name Title Board Seat Contact Info
Sylvain Berlemont Ph.D Founder & Chief Executive Officer
Nicolas Pesson Chief Financial Officer
Emmeline Bouly Chief People Officer
Mathias Monnerville Chief Information Officer
Romain Garnier Chief Product Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Keen Eye Board Members (3)

Name Representing Role Since
Karine Lignel Crédit Mutuel Equity Board Member & Strategic Advisor 000 0000
Pascale Witz Self Chairwoman 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Keen Eye Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Keen Eye Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Crédit Mutuel Equity Growth/Expansion Minority 000 0000 000000 0
Seventure Partners Venture Capital Minority 000 0000 000000 0
Incubateur Insitut de La Vision Accelerator/Incubator Minority 000 0000 000000 0
To view Keen Eye’s complete investors history, request access »